About the Course

We have designed this course to make you proficient in essential pricing and rebate concepts under Medicaid, Medicare, and other related government drug payor programs, including those under the auspices of PHS 340B, the VA, and DOW.

This year’s agenda has been refreshed and expanded to reflect the latest regulatory developments, including MFN pricing, next stage of IRA implementation, Medicare Drug Price Negotiation, PBM reform, state affordability initiatives, and the emerging TrumpRx framework and direct distribution models.

What you will achieve

  • A holistic view of key pricing and rebate concepts and methodologies.
  • Understanding pricing and rebate terms and how they may be impacted by new regulations and policy initiatives.
  • Comprehension of essential concepts and their application to more complex scenarios.

This intensive training program will give novices and experienced practitioners alike a thorough understanding of core pricing competencies and applicable changes in the reimbursement structures of key payor programs.

Gain exclusive and unparalleled access to an in-depth guide on navigating the legal and regulatory maze of prescription drug pricing and rebates.

ACI’s goal is to provide you with a live glossary of essential pricing terminology, as well as analysis of the latest developments affecting Rx drug pricing and rebates.

We will provide a complete course of study for foundational elements, as well as a strategy guide for tackling complex challenges that will benefit the industry novice and the veteran.

Let us help you master the basics and prepare for the complexities.